Omi is an ATP-independent serine protease that is necessary for neuronal function and survival. The aim of this study was to investigate the role of protease Omi in regulating differentiation of mouse neuroblastoma cells and to identify the substrate of Omi involved in this process. Methods: Mouse neuroblastoma N2a cells and Omi protease-deficient mnd2 mice were used in this study. To modulate Omi and E2F1 expression, N2a cells were transfected with expression plasmids, shRNA plasmids or siRNA. Protein levels were detected using immunoblot assays. The interaction between Omi and E2F1 was studied using immunoprecipitation, GST pulldown and in vitro cleavage assays. N2a cells were treated with 20 μmol/L retinoic acid (RA) and 1% fetal bovine serum to induce neurite outgrowth, which was measured using Image J software. Results: E2F1 was significantly increased in Omi knockdown cells and in brain lysates of mnd2 mice, and was decreased in cells overexpressing wild-type Omi, but not inactive Omi S276C. In brain lysates of mnd2 mice, endogenous E2F1 was co-immunoprecipitated with endogenous Omi. In vitro cleavage assay demonstrated that Omi directly cleaved E2F1. Treatment of N2a cells with RA induced marked differentiation and neurite outgrowth accompanied by significantly increased Omi and decreased E2F1 levels, which were suppressed by pretreatment with the specific Omi inhibitor UCF-101. Knockdown of Omi in N2a cells suppressed RA-induced neurite outgrowth, which was partially restored by knockdown of E2F1. Conclusion: Protease Omi facilitates neurite outgrowth by cleaving the transcription factor E2F1 in differentiated neuroblastoma cells; E2F1 is a substrate of Omi.
Introduction
The ATP-independent serine protease HtrA2 (also known as Omi) is a member of the high-temperature requirement factor A (HtrA) family that was originally identified as a mammalian homolog of the Escherichia coli heat-shock-induced serine protease HtrA/DegP and DegS [1] . Under normal conditions, Omi is mostly localized in the mitochondria, while some can also be found in the nucleus [2, 3] . Previous studies have concentrated on the pro-apoptotic function of Omi in non-neuronal somatic cells. With apoptotic stimuli, Omi is released from mitochondria into the cytosol, mediating cell death by caspase-dependent or -independent apoptosis [4] [5] [6] [7] . Besides apoptotic functions, Omi seems to play a physiological role in maintaining cellular homeostasis and promoting neuronal cell survival. Omi-transgenic mice showed normal development without any symptoms of apoptotic cell death [8] . Moreover, both Omi-knockout mice and mnd2 (motor neuron degeneration 2) mice, which harbor a protease-deficient Omi S276C mutant, exhibited an early onset neurodegeneration and motor abnormalities similar to Parkinson's disease (PD) [9, 10] . Missense mutations that lead to a loss of Omi protease activity have been associated with PD [11, 12] . These studies suggest that intact Omi protease activity is necessary for neuronal function and survival. Recently, increased expression of Omi has been reported during neurogenesis and neuronal development [13] . However, the mechanism by which Omi functions in neuronal development is completely unknown.
The E2F family of transcription factors comprises eight structurally related E2Fs (E2F1-8) that form as heterodimers with members of the DP family (DP-1 and DP-2). E2F1 forms complexes with DP-1, controlling various genes implicated in G 1 /S transition that contain the sequence 5' TTTSSCGC 3' (S=C or G) in the regulatory regions [14, 15] . The activity of E2F is mediated, in large part, by a direct interaction with members of the pRb family (pRb, p107, p130) [16, 17] . In quiescent cells, non-phosphorylated pRb can bind to E2F, resulting in repressed transcription and enforcing a cell-cycle block; upon entering the cell cycle, pRb is sequentially phosphorylated by cyclin D/cdk4 complexes followed by cyclin E/cdk2 complexes activation, which leads to the dissociation and activation of E2F [18, 19] . E2F1 functions in both proliferation and apoptosis [20] [21] [22] [23] [24] ; however, increasing attention has been focused on the function of E2F1 in cell differentiation. The expression of E2F1 is irreversibly downregulated during the differentiation of C2C12 myocytes [25] . Additionally, the association of GSK3β with E2F1 facilitates nerve growth factor-induced PC12 cell differentiation, and overexpression of E2F1 inhibits neurite outgrowth [26] . In this study, we identified that E2F1 is a substrate of Omi and that Omi plays a vital role in promoting neurite outgrowth by cleaving E2F1.
Materials and methods
Animals mnd2 mice (HtrA2 S276C mutant mice, C57BL/6J) and wild-type (WT) mice were obtained from Jackson Laboratory (JAX, Bar Harbor, ME, USA). The protocol to identify the genotypes of the offspring mice was provided by JAX. The mice were bred in a specific pathogen-free environment, and adequate measures were taken to minimize pain and discomfort in compliance with national regulations. All animal experiments were approved by the Animal Welfare Advisory Committee of Soochow University.
Cell culture HEK293, H1299, and mouse neuroblastoma (N2a) cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY, USA) with 10% fetal bovine serum (FBS; Gibco) and 100 μg/mL penicillin and 100 μg/mL streptomycin. All cells were cultured at the same passage number for experimental consistency.
RNA interference
The cells were transfected with oligonucleotides mixed with RNAiMax (Invitrogen, La Jolla, CA, USA), according to the manufacturer's instructions. The oligonucleotides targeting Omi sequences (si-Omi) and the negative control (NC) siRNA have been described previously [27] . The oligonucleotides to target sequences of E2F1 were purchased from Ribobio (Guangzhou, China) and their sequences were as follows: si-E2F1 sense 5'-GGAUCUGGAGACUGACCAU-3', antisense 5'-AUGGUCAGUCUCCAGAUCC-3'. 
Immunoblot analysis and antibodies

Plasmids
The Omi-related plasmids have been described previously [27] . Full-length human E2F1 complementary DNA (cDNA) was amplified using PCR from a human fetal brain cDNA library with the primers 5'-GAGGATCCCCATG-GCCTTGGCCGGGGCC-3' and 5'-GAGAATCCCGAAATC-CAGGGGGTGA-3'. The PCR product was inserted in-frame into the pGEX-5x-1 vector at the BamHI/EcoRI sites. The plasmids encoding sh-Omi or the negative control vector (LV3-NC), which contain the green fluorescence protein (GFP) sequence, were purchased from GenePharma (Shanghai, China). The sequences targeting Omi or NC in the plasmid constructs were as follows: LV3-NC 5'-TTCTCCGAACGTGTCACGTTTC-3'; and Omi-mus 5'-GGGAGTTTGTTGTTGCCATGG-3'.
RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA from mouse brains and N2a cells was isolated using TRIzol reagent (Invitrogen), and the extracted total RNA was reverse-transcribed into cDNA for PCR assays with a TransScript First-Strand cDNA Synthesis Kit (Takara, Otsu, Shiga, Japan). The primer pairs used for qRT-PCR were as follows: mouse β-actin sense 5'-TGTCCACCTTC-CAGCAGATGT-3', antisense 5'-AGCTCAGTAACAGTC-CGCCTAGA-3'; mouse E2F1 sense 5'-CTCGACTCCTCGCA-GATCG-3', antisense 5'-GATCCAGCCTCCGTTTCACC-3'; mouse cyclin E1 sense 5'-GTGGCTCCGACCTTTCAG-3', antisense 5'-CACAGTCTTGTCAATCTTGGCA-3'.
Immunoprecipitation assay
For immunoprecipitation, mnd2 mouse brain hemispheres were lysed in TSPI buffer (50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L sodium chloride, 1 mmol/L EDTA, 1% NP-40 and a complete protease inhibitor cocktail). To eliminate cell debris, the lysates were centrifuged at 12 000×g for 30 min at 4 °C. The www.nature.com/aps Ma Q et al Acta Pharmacologica Sinica npg supernatants were incubated with anti-Omi antibody or normal rabbit immunoglobulin G overnight at 4 °C. After incubation, protein G Sepharose (Roche) was used for precipitation. The beads were washed with TSPI buffer five times, and the binding proteins were eluted with SDS sample buffer for immunoblot analysis.
In vitro proteolytic cleavage assay GST, GST-E2F1, or β-casein (Sigma, Saint Louis, MO, USA) proteins were incubated in the presence of 1-3 μg of 6×His-tagged Omi in protease cleavage buffer (50 mmol/L Tris-HCl, pH 7.6, 1 mmol/L dithiothreitol) for 1 h at 37 °C. The reactions were stopped with SDS sample buffer, and the samples were boiled for 10 min. The samples were subjected to immunoblot analysis with anti-GST antibody or visualized by Coomassie brilliant blue staining.
GST pulldown assay
An aliquot containing 20 μg of GST or GST-E2F1 that was expressed in E coli strain JM109 was incubated with 30 μg of Glutathione Sepharose 4B (Amersham Biosciences, Piscataway, NJ, USA) for 30 min at 4 °C. Sepharose bound with GST or GST-E2F1 was incubated with 50 μg of His-Omi proteins from the supernatants of the E coli crude extracts in 0.25 mL of HNTG buffer (20 mmol/L HEPES-KOH, pH 7.5, 100 mmol/L NaCl, 0.1% Triton X-100, and 10% glycerol) for 1 h at 4 °C. After incubation, the beads were washed six times with 1 mL of HNTG buffer to remove the non-binding proteins. The bound proteins were eluted using SDS sample buffer and then boiled for 10 min at 95 °C. The samples were then subjected to immunoblot analysis.
Neurite outgrowth assay N2a cells were plated onto 12-well plates (6×10 5 cells per well) and cultured overnight in DMEM containing 10% fetal bovine serum; the next day, the medium was replaced by DMEM with 1% fetal bovine serum and supplemented with retinoic acid (RA) at a final concentration of 20 μmol/L for another 48 h to induce neurite outgrowth. The formation of neurites was observed using an inverted IX71 microscope system (Olympus, Tokyo, Japan). The neurite length of each cell was measured by Image J software as previously described [28] . Each well was evaluated using four different fields under a microscope. The average neurite length of nearly 200 cells is presented as the mean±SEM. 
Subcellular fractionation assay
Statistical analysis
Densitometric analysis of immunoblots from three independent experiments was implemented with Adobe Photoshop CS5 (Adobe, San Jose, CA, USA), and the data were analyzed using Origin 6.0 (OriginLab, Northampton, MA, USA). Quantitative data are presented as the mean±SEM. Statistical significance was assessed via one-way ANOVA, and the criterion of significance was set at P<0.05.
Results
Omi represses E2F1 expression
The E2F1-related signaling pathway plays an important role in PD [29] . To test whether the protein level of E2F1 was altered in mnd2 mice, we performed immunoblot analysis using total brain lysates from 25-d-old mnd2 mice and age-matched WT mice to examine E2F1 levels. As shown in Figure 1A , the E2F1 In addition, we found no alteration in the levels of E2F1 mRNA in the brains of mnd2 mice compared to those in WT mouse brains ( Figure 1B) , indicating that Omi regulates the expression of E2F1 at the post-transcriptional level. To further confirm the effects of Omi on E2F1, we used small-interfering RNA (siRNA)-mediated silencing to knock Omi down in N2a cells. E2F1 levels were higher in Omi knockdown cells than in the negative control cells (Figure 2A) , consistent with the data from in vivo studies ( Figure 1A) . Similar data were obtained using HEK293 ( Figure 2B , left panel) and H1299 cells ( Figure 2B, right panel) . In N2a cells ( Figure 2C ) or HEK293 cells ( Figure 2D ) that were transfected with hemagglutinin (HA)-tagged full-length Omi or the S276C mutant Omi, overexpression of WT Omi resulted in a decreased abundance of E2F1, whereas overexpression of S276C mutant Omi did not ( Figure 2C, 2D) . These results indicate that Omi represses the protein level of E2F1 dependent on its protease activity.
E2F1 is a substrate of Omi E2F1 is a transcription factor resident in the nucleus, and Omi mainly distributes in the mitochondria and partially in the nucleus [1] . We therefore performed a subcellular fractionation assay to further identify Omi's subcellular localization, confirming that Omi is both cytoplasmic and nuclear ( Figure  3A) . These data suggest that there may be a linkage between these two proteins. Because the increase in E2F1 abundance in both Omi-knockdown cells and mnd2 mouse brain is relevant to Omi protease activity and the mRNA level of E2F1 is not changed in mnd2 mice, we wondered whether E2F1 is a substrate of Omi. We therefore examined the interactions between Omi and E2F1. Using an Omi-specific Figure 3B ). Moreover, GST pulldown assays also showed that GST-E2F1 pulled His-Omi down, whereas GST alone did not ( Figure 3C ). These data suggest that there is a direct interaction between these two proteins. We next performed in vitro cleavage assays to identify whether Omi could cleave E2F1. In vitro cleavage assays showed that GST-E2F1 was cleaved by WT Omi but not by S276C protease activity-deficient Omi, whereas GST alone was not cleaved by Omi ( Figure 3D ). In addition, β-casein, a substrate of Omi, was cleaved by WT Omi but not by S276C Omi, demonstrating the protease activity of WT Omi and a loss of protease activity in S276C Omi ( Figure 3E ). These data indicate that E2F1 is a substrate of Omi.
Omi facilitates neurite outgrowth through E2F1
The expression of Omi is increased in NT2 cells after RA treatment and is upregulated in brain tissues with the development In vitro purified GST, GST-E2F1 proteins were incubated with WT or protease-inactive S276C Omi, respectively, for 60 min in protease buffer at 37 ºC. The incubated mixtures were subjected to immunoblot analysis with the antibodies indicated. The cleavage product is indicated using an arrow. (E) Omi cleaves the substrate β-casein in vitro. Purified His-Omi or His-Omi S276C was incubated with β-casein for 60 min in protease buffer at 37 ºC. After incubation, samples were subjected to SDS-PAGE and visualized using Coomassie bright blue staining. IP: immunoprecipition, WB: Western blot.
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Acta Pharmacologica Sinica npg of mouse brain, suggesting that Omi may play an important role in neuronal differentiation and development [13] . We therefore performed a neurite outgrowth assay using N2a cells to address whether Omi regulates neurite outgrowth in association with E2F1 expression. The mouse neuroblastoma cell line (N2a cells) is a commonly used cell line whose differentiation and neurite outgrowth can be induced by RA [30, 31] . In N2a cells, RA treatment in combination with a lower concentration of serum (1%) induced cell differentiation and neurite outgrowth, accompanied by increased Omi and decreased E2F1 levels (Figure 4A) . In addition, the average neurite length was significantly increased by RA treatment ( Figure 4B ). Moreover, in Figure 4C ). Similar results were obtained in cells with Omi knocked down by sh-Omi, demonstrating that the knockdown of Omi increased E2F1 levels ( Figure 4D ). E2F1 can control cell proliferation and differentiation. Overexpression of E2F1 significantly inhibits neuronal differentiation [26] . We have found that Omi is increased and E2F1 is decreased in differentiated N2a cells ( Figure 4A ). We further examined whether Omi activity and E2F1 levels are correlated in differentiated N2a cells to affect neurite outgrowth. Inhibition of Omi protease activity with UCF-101 dramatically decreased the average neurite length ( Figure 5A ). In addition, knocking down Omi with sh-Omi significantly inhibited neurite outgrowth in N2a cells, and knockdown of E2F1 in Omi knockdown cells partially restored neurite outgrowth ( Figure 5B and 5C ), suggesting the involvement of E2F1 in the altered neurite outgrowth observed in Omi knockdown cells.
The efficiency of si-E2F1 was proved by detecting the protein level of E2F1 in N2a cells ( Figure 5D ). Finally, to confirm that Omi could affect E2F1 transcriptional activity, we performed qRT-PCR assays to detect the mRNA of E2F1-targeted gene cyclin E1. The mRNA of cyclin E1 was upregulated in sh-Omi transfected N2a cells, and this effect was reversed by knocking down E2F1 in sh-Omi transfected cells ( Figure 5E ), suggesting that knocking down Omi increases E2F1 activity.
Discussion
Lines of evidence suggest that some neurodegenerative diseases, such as Alzheimer's disease, multiple sclerosis and PD, are related to neural differentiation disorders [32] [33] [34] . The characteristics of PD are progressive degeneration of dopaminergic neurons in the substantia nigra of the midbrain and other brain regions, and visible intracellular inclusions, known as Lewy bodies [35] . A missense mutation, G2019S, of a PDassociated protein, LRRK2, leads to reduced neurite complexity in dopaminergic neurons [36] . Overexpression of another PD-related protein, α-synuclein, also causes reduced neurite length [37, 38] . Omi is a protein associated with PD [11, 12] . The expression of Omi in the brain increases with mouse age, indicating an association of Omi with neuronal development [13] . In this study, we demonstrated that Omi regulates neuronal differentiation. Knocking down Omi or inhibiting Omi protease activity by UCF-101 in N2a cells reduces neurite outgrowth. Furthermore, increasing levels of Omi, along with decreasing levels of E2F1 (an important regulator of cell differentiation), were observed in N2a cells after differentiation was induced with RA. Moreover, knocking down Omi or inhibiting its protease activity affects neurite outgrowth. Thus, our findings suggest that Omi regulates E2F1 levels to influence neurite outgrowth.
Previous reports have indicated that Omi does locate in the nuclei [1] . To date, extensive studies have revealed the mitochondrial and cytoplasmic substrates of Omi and shown the function of Omi in these subcellular sites [4, 39, 40] ; however, the nuclear substrates and functions of Omi have not been fully explored. Omi regulates transcription by processing the transcription factor, p73, or the transcriptional regulator, Wilm's suppressor protein [2, 3] , to regulate apoptosis. In this study, we identified the transcription factor, E2F1, as a novel substrate of Omi. E2F1 plays a vital role in cell proliferation and differentiation. E2F1 contributes to cell proliferation by facilitating the passage of cells through the G 1 /S checkpoint [41, 42] . As withdrawing from the cell cycle is an important step before cell differentiation and E2F1 functions in cell proliferation, the regulation of E2F1 protein levels or transcriptional activity are critical for cell differentiation. In the nervous system, E2F1 is involved in neuronal differentiation. E2F1 significantly decreases in differentiated neuronal cells [25, 43, 44] . Thus, the factors that affect E2F1 functions are able to influence neuronal differentiation. In mouse neuroblastoma cells, overexpression of necdin, a factor that interacts with E2F1 and represses E2F1 activity, leads to neuronal differentiation [45] . In vivo mouse models also suggest that E2F1 is critical for central nervous system development [46] . Those studies suggest an involvement of E2F1 in neuronal differentiation. E2F1 can be degraded through the ubiquitin-proteasome system by its E3 ligase SCF skp2 and cleaved by calpain [47, 48] . In our study, we found that Omi interacts with and cleaves E2F1 to regulate E2F1 levels. After RA induction, an increase of Omi in N2a cells results in a decrease of E2F1, leading to neurite outgrowth in N2a cells. In summary, our findings reveal the role of Omi in N2a cell differentiation. E2F1 is a novel substrate of Omi that is regulated by Omi in N2a cell differentiation. 
